| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |